Nalls Sherbakoff Group’s CME Group CME Stock Holding History

Nalls Sherbakoff Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13	Closed	-$3.57K	–	436
2025 Q1	$3.57K	Buy	+13	New	+$3.21K	﹤0.01%	354

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nalls Sherbakoff Group's CME Position: Q2 2025 in Review

Nalls Sherbakoff Group sold out of CME Group (CME) in Q2 2025, closing a stake of 13 shares — an estimated $3.57K sold.

Nalls Sherbakoff Group first reported a position in CME in Q1 2025 and held it in 1 quarter. The position peaked at $3.57K in Q1 2025. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

Nalls Sherbakoff Group reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
Nalls Sherbakoff Group sold 13 CME Group shares in Q2 2025, an estimated $3.57K.
Nalls Sherbakoff Group first reported a position in CME Group in Q1 2025 and held it in 1 quarter.
Nalls Sherbakoff Group's CME Group position peaked at $3.57K in Q1 2025.
1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2025, filed 12 Mar 2026.